期刊文献+

以血浆作透析液的血液透析联合高容量血液滤过治疗高胆红素血症的机制研究 被引量:1

Effect of hemodialysis with plasma-based dialysate plus high volume hemofiltration on serum bilirubin in patients with heperbilirubinemia
下载PDF
导出
摘要 目的前瞻性观察以人体新鲜冰冻血浆作透析液行血液透析(HD-PBD)后继续进行高容量血液滤过(HVHF),评价其对高胆红素血症患者血清胆红素的清除机制。方法选择第四军医大学第一附属医院15例肝衰竭患者行HD-PBD治疗6h后,应用同一滤器(AV600)继续行HVHF治疗24h。全部患者分别在HD-PBD治疗初始(0h)及开始后2h、4h和6h取滤器动脉端和静脉端血液、流入端和流出端透析液,HVHF治疗0h、6h、12h和24h取滤器前及滤器后血液,同时留取滤液。观察治疗前后胆红素水平的变化。结果①HD-PBD对胆红素的清除较HVHF明显(P<0.05)。②HD-PBD治疗初始的TB溶质清除率(Kd)为(23.0±3.4)ml/min,滤器使用4~6h后弥散作用下降。③HD-PBD治疗初始通过弥散和吸附的体外清除量分别为(15.6±5.6)mmol/min和(10.3±3.2)mmol/min,滤器使用4~6h后作用下降。④HVHF以吸附清除为主,其中治疗初始吸附清除量最大,12h以后吸附清除量而滤过清除量相对恒定。⑤HD-PBD治疗初始的体外清除总量高于HVHF[(25.9±8.2)mmol/minvs(7.17±3.34)mmol/min,P<0.05。结论HD-PBD联合HVHF治疗对血清胆红素有明显降低作用,其清除机制主要为弥散和吸附,对流作用较小。 Objective To prospectively evaluate the effect of hemodialysis with fresh frozen plasmabased dialysate (HD-PBD) plus high volume hemofiltration (HVHF) for the clearance of serum bilirubin in patients with heperbilirubinemia. Methods Fifteen patients with liver failure were included in this study. After HD-PBD therapy for the first 6 hours, patients were then treated with HVHF for 24 hours using the same AV600 filter. Blood and the plasma-based dialysate from vein and artery end of the filter were taken at 0, 2, 4 and 6h during HD-PBD. Blood before and after filtration as well as the ultrafiltrate were also taken at 0, 6, 12 and 24h during HVHF. Bilirubin was determined in dialysate, ultraafiltrate and plasma. Results ① The clearance rate of serum bilirubin with HD-PBD for 6 hours was significantly higher than that with HVHF for 24 hours (P〈0.05). ② The Kd for serum total bilirubin (TB) was (23.0 ± 3.4) ml/min at the beginning of HD-PBD. After HD-PBD for 4-6 hours, the Kd for TB decreased significantly. ③ At the beginning of HD-PBD, the total clearance amount of TB by dispersion and adsorption were (15.6 ± 5.6) mmol/min and (10.3 ± 3.2) mmol/min, respectively, and then decreased significantly after using the filter for 4-6 hours. ④ In HVHF, TB was mainly removed by adsorption. After HVHF for 12h, clearance by adsorption decreased significantly, but the amount of clearance by ultrafiltration remained stable. ⑤The clearance amount of TB by HD-PBD at the beginning decreased significantly but higher than those by HVHF for 24 hours (P〈0.05). Conclusion HD-PBD plus HVHF, a newly proposed modality for patients with liver failure, can decrease serum bilirubin efficiently. Dispersion and adsorption are the major mechanisms of serum bilirubin clearance in HD-PBD, of which the ability decreased gradually after 4 hours of dialysis. Convection and adsorption are the major mechanisms of serum bilirubin clearance in HVHF, but the efficiency is relatively low.
出处 《中国血液净化》 2007年第8期415-418,共4页 Chinese Journal of Blood Purification
基金 全军"十一五"医药卫生科研基金课题(NO:06MA232)
关键词 高胆红素血症 肝衰竭 血液滤过 透析 人工 Hyperbilirubinemia Liver failure Hemofiltration Dialysis Liver Artificial
  • 相关文献

参考文献7

二级参考文献31

  • 1龚德华,季大玺,徐斌,任冰,刘云,黎磊石.以血浆作透析液治疗高胆红素血症的效果[J].肾脏病与透析肾移植杂志,2004,13(3):201-204. 被引量:16
  • 2刘宏宝,陈威,窦科峰,李振江,宋振顺,徐月清,王汉民.以血浆作透析液的血液透析在高胆红素血症中的初步应用[J].肾脏病与透析肾移植杂志,2004,13(6):539-543. 被引量:13
  • 3刘宏宝,陈威,李振江,窦科峰,宋振顺,徐月清,王汉民.以血浆作透析液的血液透析联合高容量血液滤过在高胆红素血症中的初步应用[J].中国血液净化,2005,4(6):306-309. 被引量:6
  • 4Alvares-da-Silva MR,Waechter FL,Francisconi CF,et al.Risk factors for postoperative acute renal failure at a new orthotopic liver transplantation program.Transplant Proc,1999,31:3050-3052
  • 5金惠明主编.病理生理学.北京:人民卫生出版社,1996,P193
  • 6Novelli G,Rossi M,Pretagostini R,et al.MARS(Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure.Liver,2002,22(2):43-47
  • 7Jalan R,Sen S,Steeiner C,et al. Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis.J Hepatol,2003,38(1):24-31
  • 8Reutter JC,Sanders KF,Brecher ME,et al.Incidence of allergic reactions with fresh frozen plasma or cryo-supernatant plasma in the treatment of thrombotic thrombocytopenic purpura.J Clin Apheresis,2001,16(3): 134-138
  • 9Sadamori H,Yagi T,Inagaki M,et al.High-flow-rate hemodiafiltration as a brain-support therapy proceeding to liver transplantation for hyperacute fulminant hepatic failure.Eur Gastroenterol Hepatol,2002,14(4):435-439
  • 10Mitzner SR,Stange J,Klammt S,et al. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephro1,2001,12 (suppl 17 ) :s75

共引文献23

同被引文献16

  • 1陆国平,陆铸今,张灵恩,贺骏,胡静,吴芳.脓毒症患儿的持续血液净化治疗22例分析[J].中华儿科杂志,2006,44(8):573-578. 被引量:32
  • 2Fischbach M, Edefonti A, Schroder C. Hemodialysis in children: general practical guidelines. Pediatr Nephrol, 2005, 20 ( 8 ) : 1054-1066.
  • 3Watson AR, Gartland C. European Paediatric Peritoneal Dialysis Working Group. Guidelines by an Ad Hoe European Committee for Elective Chronic Peritoneal Dialysis in Pediatric Patients. Perit Dial Int, 2001,21(3) :240-244.
  • 4Bunchman TE, McBryde KD, Mottes TE, et al. Pediatric acute renal failure: outcome by modality and disease. Pediatr Nephrol, 2001, 16(12) : 1067-1071.
  • 5BeUomo R, Ronco C, KeUum JA, et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care, 2004, 8(4) :R204-212.
  • 6Ronco C, Pohlmeier R, Tetta C. Intermittent or continuous treatment of acute renal failure? Crit Care Med, 2003, 31 (9) : 2417.
  • 7Schiffl H, Lang SM, Fischer R, et al. Daily hemodailysis and the outcome of acute renal failure. N Engl J Med, 2002, 346 (5) : 305-310.
  • 8Goldstein SL, Somers MJ, Baum MA, et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int, 2005, 67(2) : 653-658.
  • 9Kan G, Jenkins I, Rangan G, et al. Continuous haemodiafiltration compared with intermittent haemodialysis in the treatment of methanol poisoning. Nephrol Dial Transplant, 2003, 18 (12): 2665-2667.
  • 10Ronco C, BeUomo R, Homel P, et al. Effects of different doses in continuous veno-venous hemofihration on outcomes of acute renal failure: a prospective randomised trial. Lancet, 2000, 356 (9223) : 26-30.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部